The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis

International Review of Cell and Molecular Biology

Volumn 328, Issue , 2017, Pages 253-275

  Moriwaki, K ^a   Chan, F K M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

apoptosis; caspase 8; inflammasome; inflammation; MLKL; necroptosis; NF B; RIPK1; RIPK3; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; OLIGOMER; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN KINASE 3; UNCLASSIFIED DRUG; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; ENZYME ACTIVATION; INFLAMMATION; INFLAMMATORY DISEASE; NECROPTOSIS; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; ANIMAL; BIOLOGICAL MODEL; HUMAN; METABOLISM; NECROSIS; PATHOLOGY;

ANIMALS; APOPTOSIS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NECROSIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 84994460439     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2016.08.007     Document Type: Chapter

References (118)

1. Afonso, M.B., Rodrigues, P.M., Carvalho, T., Caridade, M., Borralho, P., Cortez-Pinto, H., Castro, R.E., Rodrigues, C.M., Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin. Sci. (Lond.) 129 (2015), 721–739.
2. Bertrand, M.J., Milutinovic, S., Dickson, K.M., Ho, W.C., Boudreault, A., Durkin, J., Gillard, J.W., Jaquith, J.B., Morris, S.J., Barker, P.A., cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30 (2008), 689–700.
3. Bonnet, M.C., Preukschat, D., Welz, P.S., van Loo, G., Ermolaeva, M.A., Bloch, W., Haase, I., Pasparakis, M., The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35 (2011), 572–582.
4. Burger, M.L., Leung, K.K., Bennett, M.J., Winoto, A., T cell-specific inhibition of multiple apoptotic pathways blocks negative selection and causes autoimmunity. eLife, 2014, 3.
5. Ch'en, I.L., Tsau, J.S., Molkentin, J.D., Komatsu, M., Hedrick, S.M., Mechanisms of necroptosis in T cells. J. Exp. Med. 208 (2011), 633–641.
6. Chan, F.K., Luz, N.F., Moriwaki, K., Programmed necrosis in the cross talk of cell death and inflammation. Annu. Rev. Immunol. 33 (2014), 79–106.
7. Chan, F.K., Shisler, J., Bixby, J.G., Felices, M., Zheng, L., Appel, M., Orenstein, J., Moss, B., Lenardo, M.J., A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 278 (2003), 51613–51621.
8. Chen, W., Zhou, Z., Li, L., Zhong, C.Q., Zheng, X., Wu, X., Zhang, Y., Ma, H., Huang, D., Li, W., et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J. Biol. Chem. 288 (2013), 16247–16261.
9. Cho, Y.S., Challa, S., Moquin, D., Genga, R., Ray, T.D., Guildford, M., Chan, F.K., Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137 (2009), 1112–1123.
10. Dara, L., Johnson, H., Suda, J., Win, S., Gaarde, W., Han, D., Kaplowitz, N., Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology 62 (2015), 1847–1857.
11. Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I.L., Korkina, O., Teng, X., Abbott, D., Cuny, G.D., Yuan, C., Wagner, G., et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4 (2008), 313–321.
12. Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G.D., Mitchison, T.J., Moskowitz, M.A., Yuan, J., Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1 (2005), 112–119.
13. Deutsch, M., Graffeo, C.S., Rokosh, R., Pansari, M., Ochi, A., Levie, E.M., Van Heerden, E., Tippens, D.M., Greco, S., Barilla, R., et al. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis., 6, 2015, e1759.
14. Dillon, C.P., Oberst, A., Weinlich, R., Janke, L.J., Kang, T.B., Ben-Moshe, T., Mak, T.W., Wallach, D., Green, D.R., Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep. 1 (2012), 401–407.
15. Dillon, C.P., Weinlich, R., Rodriguez, D.A., Cripps, J.G., Quarato, G., Gurung, P., Verbist, K.C., Brewer, T.L., Llambi, F., Gong, Y.N., et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157 (2014), 1189–1202.
16. Dondelinger, Y., Jouan-Lanhouet, S., Divert, T., Theatre, E., Bertin, J., Gough, P.J., Giansanti, P., Heck, A.J., Dejardin, E., Vandenabeele, P., Bertrand, M.J., NF-kappaB-Independent Role of IKKalpha/IKKbeta in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling. Mol. Cell 60 (2015), 63–76.
17. Draber, P., Kupka, S., Reichert, M., Draberova, H., Lafont, E., de Miguel, D., Spilgies, L., Surinova, S., Taraborrelli, L., Hartwig, T., et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 13 (2015), 2258–2272.
18. Dufour, F., Sasseville, A.M., Chabaud, S., Massie, B., Siegel, R.M., Langelier, Y., The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFalpha- and FasL-induced apoptosis by interacting with caspase-8. Apoptosis 16 (2011), 256–271.
19. Duong, B.H., Onizawa, M., Oses-Prieto, J.A., Advincula, R., Burlingame, A., Malynn, B.A., Ma, A., A20 restricts ubiquitination of pro-interleukin-1beta protein complexes and suppresses NLRP3 inflammasome activity. Immunity 42 (2015), 55–67.
20. Ellis, H.M., Horvitz, H.R., Genetic control of programmed cell death in the nematode C. elegans. Cell 44 (1986), 817–829.
21. Fauster, A., Rebsamen, M., Huber, K.V., Bigenzahn, J.W., Stukalov, A., Lardeau, C.H., Scorzoni, S., Bruckner, M., Gridling, M., Parapatics, K., et al. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. Cell Death Dis., 6, 2015, e1767.
22. Feng, S., Yang, Y., Mei, Y., Ma, L., Zhu, D.E., Hoti, N., Castanares, M., Wu, M., Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell. Signal. 19 (2007), 2056–2067.
23. Feoktistova, M., Geserick, P., Kellert, B., Dimitrova, D.P., Langlais, C., Hupe, M., Cain, K., MacFarlane, M., Hacker, G., Leverkus, M., cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43 (2011), 449–463.
24. Gautheron, J., Vucur, M., Reisinger, F., Cardenas, D.V., Roderburg, C., Koppe, C., Kreggenwinkel, K., Schneider, A.T., Bartneck, M., Neumann, U.P., et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol. Med. 6 (2014), 1062–1074.
25. Gerlach, B., Cordier, S.M., Schmukle, A.C., Emmerich, C.H., Rieser, E., Haas, T.L., Webb, A.I., Rickard, J.A., Anderton, H., Wong, W.W., et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471 (2011), 591–596.
26. Gunther, C., Martini, E., Wittkopf, N., Amann, K., Weigmann, B., Neumann, H., Waldner, M.J., Hedrick, S.M., Tenzer, S., Neurath, M.F., Becker, C., Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 477 (2011), 335–339.
27. Guo, H., Omoto, S., Harris, P.A., Finger, J.N., Bertin, J., Gough, P.J., Kaiser, W.J., Mocarski, E.S., Herpes simplex virus suppresses necroptosis in human cells. Cell Host Microbe 17 (2015), 243–251.
28. Gurung, P., Anand, P.K., Malireddi, R.K., Vande Walle, L., Van Opdenbosch, N., Dillon, C.P., Weinlich, R., Green, D.R., Lamkanfi, M., Kanneganti, T.D., FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J. Immunol. 192 (2014), 1835–1846.
29. He, S., Liang, Y., Shao, F., Wang, X., Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl. Acad. Sci. USA 108 (2011), 20054–20059.
30. He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., Wang, X., Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137 (2009), 1100–1111.
31. He, Y., Franchi, L., Nunez, G., TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J. Immunol. 190 (2013), 334–339.
32. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D., Korsmeyer, S.J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 (1990), 334–336.
33. Huang, Z., Wu, S.Q., Liang, Y., Zhou, X., Chen, W., Li, L., Wu, J., Zhuang, Q., Chen, C., Li, J., et al. RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe 17 (2015), 229–242.
34. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.L., Schroter, M., Burns, K., Mattmann, C., et al. Inhibition of death receptor signals by cellular FLIP. Nature 388 (1997), 190–195.
35. Jacobsen, A.V., Lowes, K.N., Tanzer, M.C., Lucet, I.S., Hildebrand, J.M., Petrie, E.J., van Delft, M.F., Liu, Z., Conos, S.A., Zhang, J.G., et al. HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death. Cell Death Dis., 7, 2016, e2051.
36. Kaczmarek, A., Vandenabeele, P., Krysko, D.V., Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38 (2013), 209–223.
37. Kagan, J.C., Magupalli, V.G., Wu, H., SMOCs: supramolecular organizing centres that control innate immunity. Nat. Rev. Immunol. 14 (2014), 821–826.
38. Kaiser, W.J., Upton, J.W., Long, A.B., Livingston-Rosanoff, D., Daley-Bauer, L.P., Hakem, R., Caspary, T., Mocarski, E.S., RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471 (2011), 368–372.
39. Kang, S., Fernandes-Alnemri, T., Rogers, C., Mayes, L., Wang, Y., Dillon, C., Roback, L., Kaiser, W., Oberst, A., Sagara, J., et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat. Commun., 6, 2015, 7515.
40. Kang, T.B., Yang, S.H., Toth, B., Kovalenko, A., Wallach, D., Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38 (2013), 27–40.
41. Kang, Y.J., Bang, B.R., Han, K.H., Hong, L., Shim, E.J., Ma, J., Lerner, R.A., Otsuka, M., Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling. Nat. Commun., 6, 2015, 8371.
42. Kasof, G.M., Prosser, J.C., Liu, D., Lorenzi, M.V., Gomes, B.C., The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria. FEBS Lett. 473 (2000), 285–291.
43. Kerr, J.F., Wyllie, A.H., Currie, A.R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972), 239–257.
44. Latz, E., Xiao, T.S., Stutz, A., Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13 (2013), 397–411.
45. Lawlor, K.E., Khan, N., Mildenhall, A., Gerlic, M., Croker, B.A., D'Cruz, A.A., Hall, C., Kaur Spall, S., Anderton, H., Masters, S.L., et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun., 6, 2015, 6282.
46. Li, D., Xu, T., Cao, Y., Wang, H., Li, L., Chen, S., Wang, X., Shen, Z., A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis. Proc. Natl. Acad. Sci. USA 112 (2015), 5017–5022.
47. Li, J., McQuade, T., Siemer, A.B., Napetschnig, J., Moriwaki, K., Hsiao, Y.S., Damko, E., Moquin, D., Walz, T., McDermott, A., et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150 (2012), 339–350.
48. Lin, J., Li, H., Yang, M., Ren, J., Huang, Z., Han, F., Huang, J., Ma, J., Zhang, D., Zhang, Z., et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep. 3 (2013), 200–210.
49. Lin, Y., Devin, A., Rodriguez, Y., Liu, Z.G., Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13 (1999), 2514–2526.
50. Linkermann, A., Brasen, J.H., Darding, M., Jin, M.K., Sanz, A.B., Heller, J.O., De Zen, F., Weinlich, R., Ortiz, A., Walczak, H., et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 110 (2013), 12024–12029.
51. Lu, J.V., Weist, B.M., van Raam, B.J., Marro, B.S., Nguyen, L.V., Srinivas, P., Bell, B.D., Luhrs, K.A., Lane, T.E., Salvesen, G.S., Walsh, C.M., Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc. Natl. Acad. Sci. USA 108 (2011), 15312–15317.
52. Luedde, M., Lutz, M., Carter, N., Sosna, J., Jacoby, C., Vucur, M., Gautheron, J., Roderburg, C., Borg, N., Reisinger, F., et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc. Res. 103 (2014), 206–216.
53. Maelfait, J., Vercammen, E., Janssens, S., Schotte, P., Haegman, M., Magez, S., Beyaert, R., Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J. Exp. Med. 205 (2008), 1967–1973.
54. Mahoney, D.J., Cheung, H.H., Mrad, R.L., Plenchette, S., Simard, C., Enwere, E., Arora, V., Mak, T.W., Lacasse, E.C., Waring, J., Korneluk, R.G., Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc. Natl. Acad. Sci. USA 105 (2008), 11778–11783.
55. Mandal, P., Berger, S.B., Pillay, S., Moriwaki, K., Huang, C., Guo, H., Lich, J.D., Finger, J., Kasparcova, V., Votta, B., et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56 (2014), 481–495.
56. McQuade, T., Cho, Y., Chan, F.K., Positive and negative phosphorylation regulates RIP1 and RIP3-induced programmed necrosis. Biochem. J. 456 (2013), 409–415.
57. Meng, L., Jin, W., Wang, X., RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality. Proc. Natl. Acad. Sci. USA 112 (2015), 11007–11012.
58. Meylan, E., Burns, K., Hofmann, K., Blancheteau, V., Martinon, F., Kelliher, M., Tschopp, J., RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 5 (2004), 503–507.
59. Mizoguchi, A., Healing of intestinal inflammation by IL-22. Inflamm. Bowel Dis. 18 (2012), 1777–1784.
60. Moriwaki, K., Balaji, S., McQuade, T., Malhotra, N., Kang, J., Chan, F.K., The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity 41 (2014), 567–578.
61. Moriwaki, K., Bertin, J., Gough, P.J., Chan, F.K.M., A RIPK3-Caspase 8 complex mediates atypical pro-IL-1b processing. J. Immunol. 194 (2015), 1938–1944.
62. Moriwaki, K., Chan, F.K., RIP3: a molecular switch for necrosis and inflammation. Genes Dev. 27 (2013), 1640–1649.
63. Moriwaki, K., Chan, F.K., Necrosis-dependent and independent signaling of the RIP kinases in inflammation. Cytokine Growth Factor Rev. 25 (2014), 167–174.
64. Moriwaki, K., Chan, F.K., Regulation of RIPK3 and RHIM-dependent necroptosis by the proteasome. J. Biol. Chem. 291 (2016), 5948–5959.
65. Murakami, Y., Matsumoto, H., Roh, M., Giani, A., Kataoka, K., Morizane, Y., Kayama, M., Thanos, A., Nakatake, S., Notomi, S., et al. Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ. 21 (2014), 270–277.
66. Murakami, Y., Matsumoto, H., Roh, M., Suzuki, J., Hisatomi, T., Ikeda, Y., Miller, J.W., Vavvas, D.G., Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration. Proc. Natl. Acad. Sci. USA 109 (2012), 14598–14603.
67. Najjar, M., Suebsuwong, C., Ray, S.S., Thapa, R.J., Maki, J.L., Nogusa, S., Shah, S., Saleh, D., Gough, P.J., Bertin, J., et al. Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. Cell Rep. 10 (2015), 1850–1860.
68. Newton, K., Dugger, D.L., Wickliffe, K.E., Kapoor, N., de Almagro, M.C., Vucic, D., Komuves, L., Ferrando, R.E., French, D.M., Webster, J., et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343 (2014), 1357–1360.
69. Newton, K., Sun, X., Dixit, V.M., Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4. Mol. Cell. Biol. 24 (2004), 1464–1469.
70. O'Donnell, M.A., Perez-Jimenez, E., Oberst, A., Ng, A., Massoumi, R., Xavier, R., Green, D.R., Ting, A.T., Caspase 8 inhibits programmed necrosis by processing CYLD. Nat. Cell Biol. 13 (2011), 1437–1442.
71. Oberst, A., Dillon, C.P., Weinlich, R., McCormick, L.L., Fitzgerald, P., Pop, C., Hakem, R., Salvesen, G.S., Green, D.R., Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471 (2011), 363–367.
72. Omoto, S., Guo, H., Talekar, G.R., Roback, L., Kaiser, W.J., Mocarski, E.S., Suppression of RIP3-dependent necroptosis by human cytomegalovirus. J. Biol. Chem. 290 (2015), 11635–11648.
73. Onizawa, M., Oshima, S., Schulze-Topphoff, U., Oses-Prieto, J.A., Lu, T., Tavares, R., Prodhomme, T., Duong, B., Whang, M.I., Advincula, R., et al. The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat. Immunol. 16 (2015), 618–627.
74. Orozco, S., Yatim, N., Werner, M.R., Tran, H., Gunja, S.Y., Tait, S.W., Albert, M.L., Green, D.R., Oberst, A., RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ. 21 (2014), 1511–1521.
75. Osborn, S.L., Diehl, G., Han, S.J., Xue, L., Kurd, N., Hsieh, K., Cado, D., Robey, E.A., Winoto, A., Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc. Natl. Acad. Sci. USA 107 (2010), 13034–13039.
76. Panayotova-Dimitrova, D., Feoktistova, M., Ploesser, M., Kellert, B., Hupe, M., Horn, S., Makarov, R., Jensen, F., Porubsky, S., Schmieder, A., et al. cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Rep. 5 (2013), 397–408.
77. Petersen, S.L., Chen, T.T., Lawrence, D.A., Marsters, S.A., Gonzalvez, F., Ashkenazi, A., TRAF2 is a biologically important necroptosis suppressor. Cell Death Differ. 22 (2015), 1846–1857.
78. Piao, X., Komazawa-Sakon, S., Nishina, T., Koike, M., Piao, J.H., Ehlken, H., Kurihara, H., Hara, M., Van Rooijen, N., Schutz, G., et al. c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis. Sci. Signal., 5, 2012, ra93.
79. Pop, C., Oberst, A., Drag, M., Van Raam, B.J., Riedl, S.J., Green, D.R., Salvesen, G.S., FLIP(L) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity. Biochem. J. 433 (2011), 447–457.
80. Ramachandran, A., McGill, M.R., Xie, Y., Ni, H.M., Ding, W.X., Jaeschke, H., Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58 (2013), 2099–2108.
81. Rodriguez, D.A., Weinlich, R., Brown, S., Guy, C., Fitzgerald, P., Dillon, C.P., Oberst, A., Quarato, G., Low, J., Cripps, J.G., et al. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death Differ. 23 (2016), 76–88.
82. Roychowdhury, S., McMullen, M.R., Pisano, S.G., Liu, X., Nagy, L.E., Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57 (2013), 1773–1783.
83. Samuel, T., Welsh, K., Lober, T., Togo, S.H., Zapata, J.M., Reed, J.C., Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J. Biol. Chem. 281 (2006), 1080–1090.
84. Shih, V.F., Davis-Turak, J., Macal, M., Huang, J.Q., Ponomarenko, J., Kearns, J.D., Yu, T., Fagerlund, R., Asagiri, M., Zuniga, E.I., Hoffmann, A., Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-kappaB pathways. Nat. Immunol. 13 (2012), 1162–1170.
85. Sun, X., Lee, J., Navas, T., Baldwin, D.T., Stewart, T.A., Dixit, V.M., RIP3, a novel apoptosis-inducing kinase. J. Biol. Chem. 274 (1999), 16871–16875.
86. Sun, X., Yin, J., Starovasnik, M.A., Fairbrother, W.J., Dixit, V.M., Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J. Biol. Chem. 277 (2002), 9505–9511.
87. Tenev, T., Bianchi, K., Darding, M., Broemer, M., Langlais, C., Wallberg, F., Zachariou, A., Lopez, J., MacFarlane, M., Cain, K., Meier, P., The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 43 (2011), 432–448.
88. Thapa, R.J., Basagoudanavar, S.H., Nogusa, S., Irrinki, K., Mallilankaraman, K., Slifker, M.J., Beg, A.A., Madesh, M., Balachandran, S., NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis. Mol. Cell. Biol. 31 (2011), 2934–2946.
89. Thapa, R.J., Nogusa, S., Chen, P., Maki, J.L., Lerro, A., Andrake, M., Rall, G.F., Degterev, A., Balachandran, S., Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc. Natl. Acad. Sci. USA 110 (2013), E3109–E3118.
90. Trichonas, G., Murakami, Y., Thanos, A., Morizane, Y., Kayama, M., Debouck, C.M., Hisatomi, T., Miller, J.W., Vavvas, D.G., Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc. Natl. Acad. Sci. USA 107 (2010), 21695–21700.
91. Tsujimoto, Y., Cossman, J., Jaffe, E., Croce, C.M., Involvement of the bcl-2 gene in human follicular lymphoma. Science 228 (1985), 1440–1443.
92. Upton, J.W., Chan, F.K., Staying alive: cell death in antiviral immunity. Mol. Cell 54 (2014), 273–280.
93. Upton, J.W., Kaiser, W.J., Mocarski, E.S., Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J. Biol. Chem. 283 (2008), 16966–16970.
94. Upton, J.W., Kaiser, W.J., Mocarski, E.S., Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7 (2010), 302–313.
95. Upton, J.W., Kaiser, W.J., Mocarski, E.S., DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11 (2012), 290–297.
96. Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W., Vandenabeele, P., Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187 (1998), 1477–1485.
97. Vercammen, D., Brouckaert, G., Denecker, G., Van de Craen, M., Declercq, W., Fiers, W., Vandenabeele, P., Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188 (1998), 919–930.
98. Vince, J.E., Pantaki, D., Feltham, R., Mace, P.D., Cordier, S.M., Schmukle, A.C., Davidson, A.J., Callus, B.A., Wong, W.W., Gentle, I.E., et al. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J. Biol. Chem. 284 (2009), 35906–35915.
99. Vince, J.E., Wong, W.W., Gentle, I., Lawlor, K.E., Allam, R., O'Reilly, L., Mason, K., Gross, O., Ma, S., Guarda, G., et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36 (2012), 215–227.
100. Vitner, E.B., Salomon, R., Farfel-Becker, T., Meshcheriakova, A., Ali, M., Klein, A.D., Platt, F.M., Cox, T.M., Futerman, A.H., RIPK3 as a potential therapeutic target for Gaucher's disease. Nat. Med. 20 (2014), 204–208.
101. Vucur, M., Reisinger, F., Gautheron, J., Janssen, J., Roderburg, C., Cardenas, D.V., Kreggenwinkel, K., Koppe, C., Hammerich, L., Hakem, R., et al. RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. Cell Rep. 4 (2013), 776–790.
102. Wang, Q., Liu, Z., Ren, J., Morgan, S., Assa, C., Liu, B., Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation. Circ. Res. 116 (2015), 600–611.
103. Wang, S., Ni, H.M., Dorko, K., Kumer, S.C., Schmitt, T.M., Nawabi, A., Komatsu, M., Huang, H., Ding, W.X., Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury. Oncotarget 7 (2016), 17681–17698.
104. Wang, X., Li, Y., Liu, S., Yu, X., Li, L., Shi, C., He, W., Li, J., Xu, L., Hu, Z., et al. Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. Proc. Natl. Acad. Sci. USA 111 (2014), 15438–15443.
105. Weinlich, R., Oberst, A., Dillon, C.P., Janke, L.J., Milasta, S., Lukens, J.R., Rodriguez, D.A., Gurung, P., Savage, C., Kanneganti, T.D., Green, D.R., Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep. 5 (2013), 340–348.
106. Welz, P.S., Wullaert, A., Vlantis, K., Kondylis, V., Fernandez-Majada, V., Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., Pasparakis, M., FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477 (2011), 330–334.
107. Weng, D., Marty-Roix, R., Ganesan, S., Proulx, M.K., Vladimer, G.I., Kaiser, W.J., Mocarski, E.S., Pouliot, K., Chan, F.K., Kelliher, M.A., et al. Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses, cell death. Proc. Natl. Acad. Sci. USA 111 (2014), 7391–7396.
108. Wertz, I.E., Newton, K., Seshasayee, D., Kusam, S., Lam, C., Zhang, J., Popovych, N., Helgason, E., Schoeffler, A., Jeet, S., et al. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 528 (2015), 370–375.
109. Wong, W.W., Vince, J.E., Lalaoui, N., Lawlor, K.E., Chau, D., Bankovacki, A., Anderton, H., Metcalf, D., O'Reilly, L., Jost, P.J., et al. cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood 123 (2014), 2562–2572.
110. Xie, T., Peng, W., Yan, C., Wu, J., Gong, X., Shi, Y., Structural insights into RIP3-mediated necroptotic signaling. Cell Rep. 5 (2013), 70–78.
111. Yabal, M., Muller, N., Adler, H., Knies, N., Gross, C.J., Damgaard, R.B., Kanegane, H., Ringelhan, M., Kaufmann, T., Heikenwalder, M., et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep. 7 (2014), 1796–1808.
112. Yeh, W.C., Itie, A., Elia, A.J., Ng, M., Shu, H.B., Wakeham, A., Mirtsos, C., Suzuki, N., Bonnard, M., Goeddel, D.V., Mak, T.W., Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12 (2000), 633–642.
113. Yu, P.W., Huang, B.C., Shen, M., Quast, J., Chan, E., Xu, X., Nolan, G.P., Payan, D.G., Luo, Y., Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr. Biol. 9 (1999), 539–542.
114. Zhang, D.W., Shao, J., Lin, J., Zhang, N., Lu, B.J., Lin, S.C., Dong, M.Q., Han, J., RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325 (2009), 332–336.
115. Zhang, H., Zhou, X., McQuade, T., Li, J., Chan, F.K., Zhang, J., Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471 (2011), 373–376.
116. Zhang, T., Zhang, Y., Cui, M., Jin, L., Wang, Y., Lv, F., Liu, Y., Zheng, W., Shang, H., Zhang, J., et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat. Med. 22 (2016), 175–182.
117. Zhou, R., Tardivel, A., Thorens, B., Choi, I., Tschopp, J., Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11 (2010), 136–140.
118. Zhou, R., Yazdi, A.S., Menu, P., Tschopp, J., A role for mitochondria in NLRP3 inflammasome activation. Nature 469 (2011), 221–225.